Published in J Oncol on August 18, 2010
A framework for deformable image registration validation in radiotherapy clinical applications. J Appl Clin Med Phys (2013) 1.08
Quantitative chemical proteomics reveals new potential drug targets in head and neck cancer. Mol Cell Proteomics (2011) 0.95
Effects of remedies made in patient setup process on residual setup errors and margins in head and neck cancer radiotherapy based on 2D image guidance. Rep Pract Oncol Radiother (2015) 0.90
Interobserver variation in parotid gland delineation: a study of its impact on intensity-modulated radiotherapy solutions with a systematic review of the literature. Br J Radiol (2012) 0.90
Estimation of adequate setup margins and threshold for position errors requiring immediate attention in head and neck cancer radiotherapy based on 2D image guidance. Radiat Oncol (2013) 0.90
Estimation of delivered dose in radiotherapy: the influence of registration uncertainty. Med Image Comput Comput Assist Interv (2011) 0.87
Comparison of CT number calibration techniques for CBCT-based dose calculation. Strahlenther Onkol (2015) 0.80
Predicting oropharyngeal tumor volume throughout the course of radiation therapy from pretreatment computed tomography data using general linear models. Med Phys (2014) 0.77
Radiation-induced CT number changes in GTV and parotid glands during the course of radiation therapy for nasopharyngeal cancer. Br J Radiol (2016) 0.77
Stopping Criteria for Log-Domain Diffeomorphic Demons Registration: An Experimental Survey for Radiotherapy Application. Technol Cancer Res Treat (2014) 0.75
Clinical outcomes of adaptive radiotherapy in head and neck cancers. Br J Radiol (2016) 0.75
Technical Note: scuda: A software platform for cumulative dose assessment. Med Phys (2016) 0.75
A modified VMAT adaptive radiotherapy for nasopharyngeal cancer patients based on CT-CT image fusion. Radiat Oncol (2013) 0.75
Adaptive Radiotherapy for Head Neck Cancer. J Maxillofac Oral Surg (2016) 0.75
Evaluating the dosimetric effect of treatment-induced changes in virally mediated head and neck cancer patients. J Med Radiat Sci (2013) 0.75
Impact of the Intra- and Inter-observer Variability in the Delineation of Parotid Glands on the Dose Calculation During Head and Neck Helical Tomotherapy. Technol Cancer Res Treat (2015) 0.75
Co-registration of cone beam CT and planning CT in head and neck IMRT dose estimation: a feasible adaptive radiotherapy strategy. Br J Radiol (2013) 0.75
Setup uncertainties and PTV margins at different anatomical levels in intensity modulated radiotherapy for nasopharyngeal cancer. Rep Pract Oncol Radiother (2017) 0.75
Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys (2002) 5.16
Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys (1999) 4.24
Validation of an accelerated 'demons' algorithm for deformable image registration in radiation therapy. Phys Med Biol (2005) 4.00
CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines. Radiother Oncol (2003) 3.78
Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys (2007) 3.34
Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys (2004) 3.21
A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys (2001) 2.85
Effect of swallowed bolus variables on oral and pharyngeal phases of swallowing. Am J Physiol (1990) 2.37
Opening mechanisms of the human upper esophageal sphincter. Am J Physiol (1989) 2.36
Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys (2005) 2.35
Image guidance for precise conformal radiotherapy. Int J Radiat Oncol Biol Phys (2003) 2.09
Adaptive replanning strategies accounting for shrinkage in head and neck IMRT. Int J Radiat Oncol Biol Phys (2009) 1.96
Intensity-modulated radiation therapy for head and neck carcinoma. Oncologist (2007) 1.94
Fast free-form deformable registration via calculus of variations. Phys Med Biol (2004) 1.91
Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22). Int J Radiat Oncol Biol Phys (2009) 1.88
The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys (2005) 1.83
Multiple regions-of-interest analysis of setup uncertainties for head-and-neck cancer radiotherapy. Int J Radiat Oncol Biol Phys (2006) 1.75
Automatic delineation of on-line head-and-neck computed tomography images: toward on-line adaptive radiotherapy. Int J Radiat Oncol Biol Phys (2007) 1.72
Reduce in variation and improve efficiency of target volume delineation by a computer-assisted system using a deformable image registration approach. Int J Radiat Oncol Biol Phys (2007) 1.69
Assessment of parotid gland dose changes during head and neck cancer radiotherapy using daily megavoltage computed tomography and deformable image registration. Int J Radiat Oncol Biol Phys (2008) 1.63
Comparison of 12 deformable registration strategies in adaptive radiation therapy for the treatment of head and neck tumors. Radiother Oncol (2008) 1.62
Setup uncertainties of anatomical sub-regions in head-and-neck cancer patients after offline CBCT guidance. Int J Radiat Oncol Biol Phys (2009) 1.57
Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol (2001) 1.51
Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys (2010) 1.49
Structural displacements in normal swallowing: a videofluoroscopic study. Dysphagia (2000) 1.43
Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: is what you plan what you get? Int J Radiat Oncol Biol Phys (2007) 1.41
Evaluation of geometric changes of parotid glands during head and neck cancer radiotherapy using daily MVCT and automatic deformable registration. Radiother Oncol (2008) 1.37
A radiographic and tomographic imaging system integrated into a medical linear accelerator for localization of bone and soft-tissue targets. Int J Radiat Oncol Biol Phys (1999) 1.37
Demons deformable registration for CBCT-guided procedures in the head and neck: convergence and accuracy. Med Phys (2009) 1.37
Inter-observer variability in the delineation of pharyngo-laryngeal tumor, parotid glands and cervical spinal cord: comparison between CT-scan and MRI. Radiother Oncol (2005) 1.32
Comparison of 2D radiographic images and 3D cone beam computed tomography for positioning head-and-neck radiotherapy patients. Int J Radiat Oncol Biol Phys (2008) 1.26
Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer. Semin Radiat Oncol (2009) 1.20
Electronic portal image assisted reduction of systematic set-up errors in head and neck irradiation. Radiother Oncol (2001) 1.17
Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study. Laryngoscope (2009) 1.11
The effect of setup uncertainty on normal tissue sparing with IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys (2001) 1.08
An automatic CT-guided adaptive radiation therapy technique by online modification of multileaf collimator leaf positions for prostate cancer. Int J Radiat Oncol Biol Phys (2005) 1.05
Evaluation of mechanical precision and alignment uncertainties for an integrated CT/LINAC system. Med Phys (2003) 1.03
Automatic online adaptive radiation therapy techniques for targets with significant shape change: a feasibility study. Phys Med Biol (2006) 1.03
Setup error in radiotherapy: on-line correction using electronic kilovoltage and megavoltage radiographs. Int J Radiat Oncol Biol Phys (2000) 1.02
A methodology to determine margins by EPID measurements of patient setup variation and motion as applied to immobilization devices. Med Phys (2004) 1.01
Three-dimensional accuracy and interfractional reproducibility of patient fixation and positioning using a stereotactic head mask system. Int J Radiat Oncol Biol Phys (2001) 1.01
Intrafraction motions of the larynx during radiotherapy. Int J Radiat Oncol Biol Phys (2003) 1.01
Tumor persistence as a predictor of outcome after radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys (1976) 1.00
Random positional variation among the skull, mandible, and cervical spine with treatment progression during head-and-neck radiotherapy. Int J Radiat Oncol Biol Phys (2009) 0.98
An on-line replanning method for head and neck adaptive radiotherapy. Med Phys (2009) 0.95
A new irradiation unit constructed of self-moving gantry-CT and linac. Int J Radiat Oncol Biol Phys (2003) 0.93
Selection and delineation of target volumes in head and neck tumors: beyond ICRU definition. Rays (2004) 0.93
Setup deviations in wedged pair irradiation of parotid gland and tonsillar tumors, measured with an electronic portal imaging device. Radiother Oncol (1995) 0.92
Assessment of the response of tumours to radiation: clinical and experimental studies. Br J Cancer Suppl (1980) 0.90
The significance of residual disease after external irradiation of squamous-cell carcinoma of the oropharynx. Radiology (1977) 0.85
Selective nodal irradiation for head and neck cancer using intensity-modulated radiotherapy: application of RTOG consensus guidelines in routine clinical practice. Int J Radiat Oncol Biol Phys (2010) 0.85
Three dimensional variability in patient positioning using bite block immobilization in 3D-conformal radiation treatment for ENT-tumors. Radiother Oncol (1997) 0.85
A computerized remote table control for fast on-line patient repositioning: implementation and clinical feasibility. Med Phys (2000) 0.83
A comparison of field-only electronic portal imaging hard copies with double exposure port films in radiation therapy treatment setup confirmation to determine its clinical application in a radiotherapy center. Int J Radiat Oncol Biol Phys (1999) 0.82
The prevention and treatment of radiotherapy - induced xerostomia. Semin Radiat Oncol (2003) 0.81
A comparison of computer-controlled versus manual on-line patient setup adjustment. J Appl Clin Med Phys (2002) 0.81
Human tumour radiobiology: clinical data. Strahlentherapie (1983) 0.77
A double exposed portal image comparison between electronic portal imaging hard copies and port films in radiation therapy treatment setup confirmation to determine its clinical application in a radiotherapy center. Int J Radiat Oncol Biol Phys (2001) 0.77
Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys (2007) 6.98
Validation of an accelerated 'demons' algorithm for deformable image registration in radiation therapy. Phys Med Biol (2005) 4.00
Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys (2004) 3.21
Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys (2005) 3.19
Estimation of α/β for late rectal toxicity based on RTOG 94-06. Int J Radiat Oncol Biol Phys (2011) 2.96
4D Proton treatment planning strategy for mobile lung tumors. Int J Radiat Oncol Biol Phys (2007) 2.80
Ultrasound-based localization. Semin Radiat Oncol (2005) 2.52
Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer. Int J Radiat Oncol Biol Phys (2007) 2.35
Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2008) 2.22
Objective assessment of deformable image registration in radiotherapy: a multi-institution study. Med Phys (2008) 2.15
Image-guided radiation therapy for non-small cell lung cancer. J Thorac Oncol (2008) 1.90
Implementation and validation of a three-dimensional deformable registration algorithm for targeted prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys (2005) 1.87
Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2002) 1.85
Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys (2006) 1.85
Dosimetry tools and techniques for IMRT. Med Phys (2011) 1.84
Multiple regions-of-interest analysis of setup uncertainties for head-and-neck cancer radiotherapy. Int J Radiat Oncol Biol Phys (2006) 1.75
Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2004) 1.73
Reduce in variation and improve efficiency of target volume delineation by a computer-assisted system using a deformable image registration approach. Int J Radiat Oncol Biol Phys (2007) 1.69
Circulating MiR-125b as a marker predicting chemoresistance in breast cancer. PLoS One (2012) 1.67
Reducing metal artifacts in cone-beam CT images by preprocessing projection data. Int J Radiat Oncol Biol Phys (2006) 1.65
Effectiveness of noncoplanar IMRT planning using a parallelized multiresolution beam angle optimization method for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys (2005) 1.63
Adaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial. Int J Radiat Oncol Biol Phys (2011) 1.59
DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer. Gastric Cancer (2014) 1.56
Use of deformed intensity distributions for on-line modification of image-guided IMRT to account for interfractional anatomic changes. Int J Radiat Oncol Biol Phys (2005) 1.49
Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys (2010) 1.49
Targeted genomic sequencing identifies PRRT2 mutations as a cause of paroxysmal kinesigenic choreoathetosis. J Med Genet (2011) 1.49
Protective effect of a coffee preparation (Nescafe pure) against carbon tetrachloride-induced liver fibrosis in rats. Clin Nutr (2010) 1.48
Performance evaluation of automatic anatomy segmentation algorithm on repeat or four-dimensional computed tomography images using deformable image registration method. Int J Radiat Oncol Biol Phys (2008) 1.47
Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: is what you plan what you get? Int J Radiat Oncol Biol Phys (2007) 1.41
Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment. Int J Radiat Oncol Biol Phys (2007) 1.40
Epidemiology of gastroesophageal reflux disease: a general population-based study in Xi'an of Northwest China. World J Gastroenterol (2004) 1.36
Monte Carlo simulations of the dosimetric impact of radiopaque fiducial markers for proton radiotherapy of the prostate. Phys Med Biol (2007) 1.35
Comprehensive analysis of proton range uncertainties related to patient stopping-power-ratio estimation using the stoichiometric calibration. Phys Med Biol (2012) 1.34
Intrafraction prostate motion during IMRT for prostate cancer. Int J Radiat Oncol Biol Phys (2002) 1.33
A beam-specific planning target volume (PTV) design for proton therapy to account for setup and range uncertainties. Int J Radiat Oncol Biol Phys (2011) 1.31
An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committee. Radiother Oncol (2012) 1.28
Comparison of 2D radiographic images and 3D cone beam computed tomography for positioning head-and-neck radiotherapy patients. Int J Radiat Oncol Biol Phys (2008) 1.26
Accuracy of two heterogeneity dose calculation algorithms for IMRT in treatment plans designed using an anthropomorphic thorax phantom. Med Phys (2007) 1.26
miR-30 inhibits TGF-β1-induced epithelial-to-mesenchymal transition in hepatocyte by targeting Snail1. Biochem Biophys Res Commun (2011) 1.25
Patterns of disease recurrence following treatment of oropharyngeal cancer with intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys (2012) 1.23
Evaluation of respiratory-induced target motion for esophageal tumors at the gastroesophageal junction. Radiother Oncol (2007) 1.23
Automatic registration of the prostate for computed-tomography-guided radiotherapy. Med Phys (2003) 1.21
Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model. Int J Radiat Oncol Biol Phys (2010) 1.21
Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy. Int J Radiat Oncol Biol Phys (2004) 1.20
Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2007) 1.17
Automatic segmentation of whole breast using atlas approach and deformable image registration. Int J Radiat Oncol Biol Phys (2008) 1.15
A deformable image registration method to handle distended rectums in prostate cancer radiotherapy. Med Phys (2006) 1.14
Osteoradionecrosis and radiation dose to the mandible in patients with oropharyngeal cancer. Int J Radiat Oncol Biol Phys (2012) 1.13
Experience of ultrasound-based daily prostate localization. Int J Radiat Oncol Biol Phys (2003) 1.12
Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study. Int J Radiat Oncol Biol Phys (2011) 1.11
Characterization of microRNA-29 family expression and investigation of their mechanistic roles in gastric cancer. Carcinogenesis (2013) 1.11
Characterization of rectal normal tissue complication probability after high-dose external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2004) 1.11
Simultaneous regeneration of articular cartilage and subchondral bone in vivo using MSCs induced by a spatially controlled gene delivery system in bilayered integrated scaffolds. Biomaterials (2011) 1.11
Involvement of testicular growth factors in fetal Leydig cell aggregation after exposure to phthalate in utero. Proc Natl Acad Sci U S A (2008) 1.09
Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys (2006) 1.09
Quality assurance for image-guided radiation therapy utilizing CT-based technologies: a report of the AAPM TG-179. Med Phys (2012) 1.09
MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway. J Pathol (2014) 1.08
Hazards of dose escalation in prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys (2003) 1.08
Adaptive radiotherapy for head and neck cancer--dosimetric results from a prospective clinical trial. Radiother Oncol (2013) 1.05
Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome. World J Gastroenterol (2007) 1.05
An automatic CT-guided adaptive radiation therapy technique by online modification of multileaf collimator leaf positions for prostate cancer. Int J Radiat Oncol Biol Phys (2005) 1.05
Evaluation of mechanical precision and alignment uncertainties for an integrated CT/LINAC system. Med Phys (2003) 1.03
Evaluation of a contour-alignment technique for CT-guided prostate radiotherapy: an intra- and interobserver study. Int J Radiat Oncol Biol Phys (2004) 1.03
The autoregulatory feedback loop of microRNA-21/programmed cell death protein 4/activation protein-1 (MiR-21/PDCD4/AP-1) as a driving force for hepatic fibrosis development. J Biol Chem (2013) 1.03
Dose constraints to prevent radiation-induced brachial plexopathy in patients treated for lung cancer. Int J Radiat Oncol Biol Phys (2012) 1.03
Comparison of temperature curve and ablation zone between 915- and 2450-MHz cooled-shaft microwave antenna: results in ex vivo porcine livers. Eur J Radiol (2011) 1.01
Long non-coding RNA LSINCT5 predicts negative prognosis and exhibits oncogenic activity in gastric cancer. Medicine (Baltimore) (2014) 1.01
Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway. Toxicology (2012) 1.01
Elastic image mapping for 4-D dose estimation in thoracic radiotherapy. Radiat Prot Dosimetry (2005) 1.00
Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys (2005) 1.00
Estrogen reduces CCL4- induced liver fibrosis in rats. World J Gastroenterol (2002) 1.00
Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06. Int J Radiat Oncol Biol Phys (2012) 1.00
Quantification of prostate and seminal vesicle interfraction variation during IMRT. Int J Radiat Oncol Biol Phys (2008) 0.99
Effectiveness of using fewer implanted fiducial markers for prostate target alignment. Int J Radiat Oncol Biol Phys (2009) 0.99
Speed and convergence properties of gradient algorithms for optimization of IMRT. Med Phys (2004) 0.99
Transcriptome analysis of tree peony during chilling requirement fulfillment: assembling, annotation and markers discovering. Gene (2011) 0.99
Chlorogenic acid against carbon tetrachloride-induced liver fibrosis in rats. Eur J Pharmacol (2009) 0.98
Dosimetric accuracy of Kodak EDR2 film for IMRT verifications. Med Phys (2005) 0.98
Proton radiotherapy for liver tumors: dosimetric advantages over photon plans. Med Dosim (2008) 0.98
Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers. Med Phys (2013) 0.97
Dose-volume response analyses of late rectal bleeding after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2004) 0.96
Antibacterial prenylflavone derivatives from Psoralea corylifolia, and their structure-activity relationship study. Bioorg Med Chem (2004) 0.96
Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer. Med Dosim (2005) 0.96
A physiologically active polysaccharide hydrogel promotes wound healing. J Biomed Mater Res A (2010) 0.96
Evaluation of tumor position and PTV margins using image guidance and respiratory gating. Int J Radiat Oncol Biol Phys (2010) 0.95
Double acoustic microresonator quartz-enhanced photoacoustic spectroscopy. Opt Lett (2014) 0.95
The use of rectal balloon during the delivery of intensity modulated radiotherapy (IMRT) for prostate cancer: more than just a prostate gland immobilization device? Cancer J (2002) 0.95
Tumor-volume simulation during radiotherapy for head-and-neck cancer using a four-level cell population model. Int J Radiat Oncol Biol Phys (2009) 0.95
Physics controversies in proton therapy. Semin Radiat Oncol (2013) 0.94
Improved cartilage regeneration utilizing mesenchymal stem cells in TGF-beta1 gene-activated scaffolds. Tissue Eng Part A (2009) 0.94
Beam angle optimization and reduction for intensity-modulated radiation therapy of non-small-cell lung cancers. Int J Radiat Oncol Biol Phys (2006) 0.93
A regulatory circuit comprising GATA1/2 switch and microRNA-27a/24 promotes erythropoiesis. Nucleic Acids Res (2013) 0.93
Antifungal diterpenoids of Pseudolarix kaempferi, and their structure-activity relationship study. Bioorg Med Chem (2003) 0.92
Dose sculpting with generalized equivalent uniform dose. Med Phys (2005) 0.92
MicroRNA-219-2-3p functions as a tumor suppressor in gastric cancer and is regulated by DNA methylation. PLoS One (2013) 0.92
Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation. Int J Radiat Oncol Biol Phys (2003) 0.92
A comprehensive analysis of GATA-1-regulated miRNAs reveals miR-23a to be a positive modulator of erythropoiesis. Nucleic Acids Res (2013) 0.91
Preparation and characterization of solid lipid nanoparticles loaded traditional Chinese medicine. Int J Biol Macromol (2006) 0.91
Dose-response for biochemical control among high-risk prostate cancer patients after external beam radiotherapy. Int J Radiat Oncol Biol Phys (2003) 0.91
Composite score of reflux symptoms in diagnosis of gastroesophageal reflux disease. World J Gastroenterol (2004) 0.91